| (+)-alpha-tocopherol | increases expression | ISO | RGD:621511 | 6480464 | alpha-Tocopherol results in increased expression of CTSD protein | CTD | PMID:18942769 |
| (+)-pilocarpine | increases expression | ISO | RGD:621511 | 6480464 | Pilocarpine results in increased expression of CTSD mRNA | CTD | PMID:17971868 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:621511 | 6480464 | epigallocatechin gallate inhibits the reaction [Isoproterenol affects the activity of CTSD protein] | CTD | PMID:18294627 |
| (R)-lipoic acid | multiple interactions | ISO | RGD:621511 | 6480464 | Thioctic Acid inhibits the reaction [Doxorubicin results in decreased activity of CTSD protein] | CTD | PMID:12841641 |
| (S)-amphetamine | decreases expression | EXP | | 6480464 | Dextroamphetamine results in decreased expression of CTSD mRNA | CTD | PMID:12558987 |
| 1,2,4-trimethylbenzene | decreases expression | ISO | RGD:621511 | 6480464 | pseudocumene results in decreased expression of CTSD protein | CTD | PMID:17337753 |
| 17beta-estradiol | increases secretion | ISO | RGD:1351014 | 6480464 | Estradiol results in increased secretion of CTSD protein | CTD | PMID:2278856 more ... |
| 17beta-estradiol | increases secretion | ISO | RGD:1351014 | 6480464 | Estradiol results in increased secretion of CTSD protein | CTD | PMID:2278856 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD mRNA | CTD | PMID:10411295 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased secretion of CTSD protein | CTD | PMID:7909315 |
| 17beta-estradiol | increases secretion | ISO | RGD:1351014 | 6480464 | Estradiol results in increased secretion of CTSD protein | CTD | PMID:2278856 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | [Estradiol results in increased activity of ESR1 protein] which results in increased expression of CTSD mRNA | CTD | PMID:22403704 |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD mRNA | CTD | PMID:10411295 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | CTD | PMID:11165043 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD protein | CTD | PMID:22235307 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | 3',4'-dimethoxy-alpha-naphthoflavone inhibits the reaction [Estradiol results in increased expression of CTSD mRNA]; more ... | CTD | PMID:22235307 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | CTD | PMID:19365803 PMID:19654927 |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD mRNA | CTD | PMID:10411295 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD mRNA | CTD | PMID:10411295 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD mRNA | CTD | PMID:19654927 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | CTD | PMID:11179685 PMID:11165043 |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD mRNA | CTD | PMID:15090535 more ... |
| 17beta-estradiol | increases secretion | ISO | RGD:1351014 | 6480464 | Estradiol results in increased secretion of CTSD protein | CTD | PMID:8384872 PMID:2278856 |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD mRNA | CTD | PMID:11179685 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | Estradiol promotes the reaction [[ESR1 protein binds to CTSD promoter] which results in increased expression of CTSD mRNA] | CTD | PMID:11165043 PMID:11165043 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | CTD | PMID:19654927 |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD mRNA | CTD | PMID:19619570 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased secretion of CTSD protein] | CTD | PMID:2278856 PMID:8384872 |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD mRNA | CTD | PMID:11165043 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased secretion of CTSD protein modified form] | CTD | PMID:2278856 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased secretion of CTSD protein] | CTD | PMID:8384872 PMID:2278856 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | CTD | PMID:11165043 PMID:11179685 |
| 17beta-estradiol | increases secretion | ISO | RGD:1351014 | 6480464 | Estradiol results in increased secretion of CTSD protein modified form | CTD | PMID:2278856 |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD mRNA | CTD | PMID:19619570 more ... |
| 17beta-estradiol | increases secretion | ISO | RGD:1351014 | 6480464 | Estradiol results in increased secretion of CTSD protein | CTD | PMID:2278856 PMID:8384872 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CTSD mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | Estradiol promotes the reaction [ESR1 protein binds to CTSD promoter] | CTD | PMID:19698761 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA]]; more ... | CTD | PMID:11165043 |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD protein | CTD | PMID:22235307 PMID:8524236 |
| 17beta-estradiol | increases expression | ISO | RGD:1351014 | 6480464 | Estradiol results in increased expression of CTSD mRNA | CTD | PMID:10411295 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased secretion of CTSD protein] | CTD | PMID:2278856 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD protein] | CTD | PMID:22235307 PMID:8524236 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | CTD | PMID:11165043 more ... |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | decreases expression | ISO | RGD:1351014 | 6480464 | Metribolone results in decreased expression of CTSD protein | CTD | PMID:17152098 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased secretion of CTSD protein modified form] | CTD | PMID:2278856 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases secretion | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin results in increased secretion of CTSD protein | CTD | PMID:7909315 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased secretion of CTSD protein | CTD | PMID:7909315 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | CTD | PMID:11165043 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD protein] | CTD | PMID:22235307 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CTSD mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD protein] | CTD | PMID:22235307 PMID:8524236 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | CTD | PMID:11165043 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased secretion of CTSD protein] | CTD | PMID:2278856 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased secretion of CTSD protein] | CTD | PMID:2278856 PMID:8384872 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | CTD | PMID:11165043 PMID:11179685 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased secretion of CTSD protein] | CTD | PMID:8384872 PMID:2278856 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | CTD | PMID:11179685 PMID:11165043 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CTSD mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1351014 | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA]]; more ... | CTD | PMID:11165043 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CTSD mRNA | CTD | PMID:11879969 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1351014 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CTSD mRNA | CTD | PMID:19619570 |
| 2-amino-2-deoxy-D-glucopyranose | affects localization | ISO | RGD:1351014 | 6480464 | Glucosamine affects the localization of CTSD protein | CTD | PMID:15972124 |
| 2-amino-2-deoxy-D-glucopyranose | increases activity | ISO | RGD:1351014 | 6480464 | Glucosamine results in increased activity of CTSD protein | CTD | PMID:16850161 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:1351014 | 6480464 | Glucosamine results in decreased expression of CTSD protein alternative form | CTD | PMID:16850161 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:1351014 | 6480464 | pepstatin inhibits the reaction [Glucosamine results in decreased expression of CTSD protein alternative form] | CTD | PMID:16850161 |
| 2-butoxyethanol | increases expression | EXP | | 6480464 | n-butoxyethanol results in increased expression of CTSD mRNA | CTD | PMID:19812364 |
| 2-nitrofluorene | increases expression | ISO | RGD:621511 | 6480464 | 2-nitrofluorene results in increased expression of CTSD mRNA | CTD | PMID:15890375 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases activity | ISO | RGD:621511 | 6480464 | Puromycin Aminonucleoside results in increased activity of CTSD protein | CTD | PMID:6497855 |
| 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CTSD mRNA | CTD | PMID:20188158 |
| 3-methylcholanthrene | increases expression | ISO | RGD:1351014 | 6480464 | Methylcholanthrene results in increased expression of CTSD mRNA | CTD | PMID:16257430 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | RGD:621511 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CTSD mRNA | CTD | PMID:15890375 |
| 6alpha-methylprednisolone | multiple interactions | ISO | RGD:621511 | 6480464 | Methylprednisolone inhibits the reaction [Isoproterenol results in increased expression of CTSD mRNA] | CTD | PMID:894732 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:621511 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTSD mRNA | CTD | PMID:12097258 |
| aflatoxin B1 | increases expression | ISO | RGD:621511 | 6480464 | Aflatoxin B1 results in increased expression of CTSD mRNA | CTD | PMID:15890375 |
| aldehydo-D-glucosamine | affects localization | ISO | RGD:1351014 | 6480464 | Glucosamine affects the localization of CTSD protein | CTD | PMID:15972124 |
| aldehydo-D-glucosamine | increases activity | ISO | RGD:1351014 | 6480464 | Glucosamine results in increased activity of CTSD protein | CTD | PMID:16850161 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:1351014 | 6480464 | Glucosamine results in decreased expression of CTSD protein alternative form | CTD | PMID:16850161 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:1351014 | 6480464 | pepstatin inhibits the reaction [Glucosamine results in decreased expression of CTSD protein alternative form] | CTD | PMID:16850161 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1351014 | 6480464 | Tretinoin results in increased expression of CTSD mRNA | CTD | PMID:17218384 PMID:16054129 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1351014 | 6480464 | Tretinoin results in increased expression of CTSD mRNA | CTD | PMID:15498508 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:1351014 | 6480464 | Tretinoin results in increased expression of CTSD mRNA | CTD | PMID:15498508 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:1351014 | 6480464 | Tretinoin results in increased expression of CTSD mRNA | CTD | PMID:17218384 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:1351014 | 6480464 | Tretinoin results in increased expression of CTSD mRNA | CTD | PMID:16054129 more ... |
| amlodipine | multiple interactions | ISO | RGD:621511 | 6480464 | [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:11829124 PMID:14499179 |
| amlodipine | multiple interactions | ISO | RGD:621511 | 6480464 | [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:14499179 PMID:11829124 |
| amlodipine | multiple interactions | ISO | RGD:621511 | 6480464 | [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein] | CTD | PMID:14499179 |
| ammonium chloride | increases expression | ISO | RGD:621511 | 6480464 | Ammonium Chloride results in increased expression of CTSD protein | CTD | PMID:16483693 |
| ammonium chloride | affects expression | ISO | RGD:621511 | 6480464 | Ammonium Chloride affects the expression of CTSD mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1351014 | 6480464 | Benzo(a)pyrene results in decreased expression of CTSD mRNA | CTD | PMID:17879257 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1351014 | 6480464 | fulvestrant inhibits the reaction [Benzo(a)pyrene results in increased expression of CTSD mRNA]; more ... | CTD | PMID:19365803 |
| benzo[a]pyrene | increases expression | ISO | RGD:1351014 | 6480464 | Benzo(a)pyrene analog results in increased expression of CTSD mRNA; more ... | CTD | PMID:19365803 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CTSD mRNA | CTD | PMID:21715664 PMID:22228805 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CTSD mRNA | CTD | PMID:21715664 |
| beta-D-glucosamine | affects localization | ISO | RGD:1351014 | 6480464 | Glucosamine affects the localization of CTSD protein | CTD | PMID:15972124 |
| beta-D-glucosamine | decreases expression | ISO | RGD:1351014 | 6480464 | Glucosamine results in decreased expression of CTSD protein alternative form | CTD | PMID:16850161 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:1351014 | 6480464 | pepstatin inhibits the reaction [Glucosamine results in decreased expression of CTSD protein alternative form] | CTD | PMID:16850161 |
| beta-D-glucosamine | increases activity | ISO | RGD:1351014 | 6480464 | Glucosamine results in increased activity of CTSD protein | CTD | PMID:16850161 |
| bisphenol A | multiple interactions | ISO | RGD:1351014 | 6480464 | [bisphenol A results in increased activity of ESR1 protein] which results in increased expression of CTSD mRNA | CTD | PMID:14754635 |
| bisphenol A | multiple interactions | ISO | RGD:1351014 | 6480464 | [bisphenol A results in increased activity of ESR1 protein] which results in increased expression of CTSD mRNA | CTD | PMID:14754635 PMID:22403704 |
| cadmium dichloride | increases expression | ISO | RGD:1351014 | 6480464 | Cadmium Chloride results in increased expression of CTSD | CTD | PMID:22041583 |
| cadmium dichloride | decreases expression | ISO | RGD:621511 | 6480464 | Cadmium Chloride results in decreased expression of CTSD mRNA | CTD | PMID:21297351 |
| cadmium dichloride | multiple interactions | ISO | RGD:1351014 | 6480464 | Melatonin inhibits the reaction [Cadmium Chloride results in increased expression of CTSD] | CTD | PMID:22041583 |
| chloroquine | affects localization | ISO | RGD:621511 | 6480464 | Chloroquine affects the localization of CTSD protein | CTD | PMID:7715800 |
| chloroquine | increases expression | ISO | RGD:621511 | 6480464 | Chloroquine results in increased expression of CTSD protein | CTD | PMID:2759144 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CTSD mRNA | CTD | PMID:20938992 |
| cimetidine | decreases activity | ISO | RGD:621511 | 6480464 | Cimetidine results in decreased activity of CTSD protein | CTD | PMID:12903910 |
| cis-caffeic acid | multiple interactions | ISO | RGD:621511 | 6480464 | caffeic acid inhibits the reaction [Isoproterenol affects the activity of CTSD protein] | CTD | PMID:20391626 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of CTSD mRNA | CTD | PMID:21151649 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CTSD mRNA | CTD | PMID:17585979 |
| cobalt dichloride | increases expression | ISO | RGD:1351014 | 6480464 | cobaltous chloride results in increased expression of CTSD mRNA | CTD | PMID:19320972 PMID:19376846 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of CTSD mRNA | CTD | PMID:15681117 |
| copper atom | multiple interactions | ISO | RGD:1351014 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of CTSD mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1351014 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of CTSD mRNA | CTD | PMID:20971185 |
| curcumin | multiple interactions | ISO | RGD:621511 | 6480464 | Curcumin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein]; more ... | CTD | PMID:8534267 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | [Cyclophosphamide co-treated with Mecamylamine] results in increased expression of CTSD mRNA | CTD | PMID:18433785 |
| cyclosporin A | increases expression | ISO | RGD:1351014 | 6480464 | Cyclosporine results in increased expression of CTSD mRNA | CTD | PMID:20106945 |
| cysteamine | increases expression | ISO | RGD:621511 | 6480464 | Cysteamine results in increased expression of CTSD protein | CTD | PMID:20165931 |
| cysteamine | multiple interactions | ISO | RGD:621511 | 6480464 | thamira parpam inhibits the reaction [Cysteamine results in increased expression of CTSD protein]; more ... | CTD | PMID:20165931 |
| DDT | multiple interactions | ISO | RGD:1351014 | 6480464 | [DDT results in increased activity of ESR1 protein] which results in increased expression of CTSD mRNA | CTD | PMID:22403704 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:1351014 | 6480464 | Tetrahydrocannabinol results in increased expression of CTSD protein; more ... | CTD | PMID:18163980 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CTSD mRNA | CTD | PMID:21041162 |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | alliin affects the reaction [Isoproterenol affects the activity of CTSD protein] | CTD | PMID:17623887 |
| diazoxide | affects activity | ISO | RGD:621511 | 6480464 | Isoproterenol affects the activity of CTSD protein | CTD | PMID:17623887 more ... |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | epigallocatechin gallate inhibits the reaction [Isoproterenol affects the activity of CTSD protein] | CTD | PMID:18294627 |
| diazoxide | affects activity | ISO | RGD:621511 | 6480464 | Isoproterenol affects the activity of CTSD protein | CTD | PMID:17623887 PMID:20391626 |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | caffeic acid inhibits the reaction [Isoproterenol affects the activity of CTSD protein] | CTD | PMID:20391626 |
| diazoxide | increases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased activity of CTSD protein | CTD | PMID:11829124 more ... |
| diazoxide | increases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased activity of CTSD protein | CTD | PMID:17188415 more ... |
| diazoxide | decreases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in decreased activity of CTSD protein | CTD | PMID:14499179 more ... |
| diazoxide | increases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased activity of CTSD protein | CTD | PMID:14499179 more ... |
| diazoxide | increases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased activity of CTSD protein | CTD | PMID:17188415 more ... |
| diazoxide | decreases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in decreased activity of CTSD protein | CTD | PMID:14499179 more ... |
| diazoxide | increases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased activity of CTSD protein | CTD | PMID:21762681 more ... |
| diazoxide | decreases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in decreased activity of CTSD protein | CTD | PMID:19172585 more ... |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:11829124 PMID:14499179 |
| diazoxide | increases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased activity of CTSD protein | CTD | PMID:19641666 more ... |
| diazoxide | increases expression | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased expression of CTSD mRNA | CTD | PMID:17182065 PMID:894732 |
| diazoxide | decreases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in decreased activity of CTSD protein | CTD | PMID:8534267 more ... |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | Ellagic Acid inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:21762681 |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | S-allylcysteine inhibits the reaction [Isoproterenol results in increased expression of CTSD mRNA] | CTD | PMID:17182065 |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | Plant Extracts inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:19641666 |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:14499179 PMID:11829124 |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein] | CTD | PMID:14499179 |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | naringin inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:17188415 |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | Methylprednisolone inhibits the reaction [Isoproterenol results in increased expression of CTSD mRNA] | CTD | PMID:894732 |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein] | CTD | PMID:19172585 |
| diazoxide | increases expression | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased expression of CTSD protein | CTD | PMID:18424012 |
| diazoxide | increases expression | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased expression of CTSD mRNA | CTD | PMID:894732 PMID:17182065 |
| diazoxide | increases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased activity of CTSD protein | CTD | PMID:8534267 more ... |
| diazoxide | decreases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in decreased activity of CTSD protein | CTD | PMID:8534267 more ... |
| diazoxide | affects activity | ISO | RGD:621511 | 6480464 | Isoproterenol affects the activity of CTSD protein | CTD | PMID:17623887 |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | [ferulic acid co-treated with Ascorbic Acid] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:17045618 |
| diazoxide | multiple interactions | ISO | RGD:621511 | 6480464 | Curcumin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein]; more ... | CTD | PMID:8534267 |
| dibutyl phthalate | decreases expression | ISO | RGD:621511 | 6480464 | Dibutyl Phthalate results in decreased expression of CTSD mRNA | CTD | PMID:17379624 |
| diethylstilbestrol | increases expression | ISO | RGD:621511 | 6480464 | Diethylstilbestrol results in increased expression of CTSD mRNA | CTD | PMID:15890375 |
| disodium cromoglycate | multiple interactions | EXP | | 6480464 | [pristane co-treated with Cromolyn Sodium] results in increased expression of CTSD protein | CTD | PMID:8812242 |
| diuron | decreases expression | ISO | RGD:621511 | 6480464 | Diuron results in decreased expression of CTSD mRNA | CTD | PMID:21551480 |
| doxorubicin | decreases response to substance | ISO | RGD:1351014 | 6480464 | CTSD protein results in decreased susceptibility to Doxorubicin | CTD | PMID:18566016 |
| doxorubicin | decreases activity | ISO | RGD:621511 | 6480464 | Doxorubicin results in decreased activity of CTSD protein | CTD | PMID:12841641 |
| doxorubicin | multiple interactions | ISO | RGD:621511 | 6480464 | Thioctic Acid inhibits the reaction [Doxorubicin results in decreased activity of CTSD protein] | CTD | PMID:12841641 |
| doxorubicin | decreases expression | ISO | RGD:621511 | 6480464 | Doxorubicin results in decreased expression of CTSD mRNA | CTD | PMID:19915844 |
| doxorubicin | increases expression | ISO | RGD:1351014 | 6480464 | Doxorubicin results in increased expression of CTSD protein | CTD | PMID:18566016 |
| ellagic acid | multiple interactions | ISO | RGD:621511 | 6480464 | Ellagic Acid inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:21762681 |
| emodin | decreases expression | ISO | RGD:1351014 | 6480464 | Emodin results in decreased expression of CTSD mRNA | CTD | PMID:16045814 |
| ethambutol | multiple interactions | ISO | RGD:621511 | 6480464 | Ethambutol results in increased expression of and affects the localization of CTSD protein; more ... | CTD | PMID:19063910 |
| ferulic acid | multiple interactions | ISO | RGD:621511 | 6480464 | [ferulic acid co-treated with Ascorbic Acid] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:17045618 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CTSD mRNA | CTD | PMID:20938992 |
| fulvestrant | increases expression | ISO | RGD:1351014 | 6480464 | fulvestrant results in increased expression of CTSD mRNA | CTD | PMID:15072547 |
| fulvestrant | decreases expression | ISO | RGD:1351014 | 6480464 | fulvestrant results in decreased expression of CTSD mRNA | CTD | PMID:14750165 |
| fulvestrant | multiple interactions | ISO | RGD:1351014 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | CTD | PMID:19365803 PMID:19654927 |
| fulvestrant | multiple interactions | ISO | RGD:1351014 | 6480464 | fulvestrant inhibits the reaction [Benzo(a)pyrene analog results in increased expression of CTSD mRNA]; more ... | CTD | PMID:19365803 |
| fulvestrant | multiple interactions | ISO | RGD:1351014 | 6480464 | fulvestrant inhibits the reaction [1,7-diphenyl-5-heptene-3-one results in increased expression of CTSD mRNA]; more ... | CTD | PMID:19654927 |
| fumonisin B1 | increases expression | EXP | | 6480464 | fumonisin B1 results in increased expression of CTSD mRNA | CTD | PMID:16221962 |
| genistein | increases expression | ISO | RGD:1351014 | 6480464 | Genistein results in increased expression of CTSD mRNA | CTD | PMID:15090535 |
| genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of CTSD mRNA | CTD | PMID:21048042 |
| hydrogen peroxide | affects expression | ISO | RGD:1351014 | 6480464 | Hydrogen Peroxide affects the expression of CTSD protein | CTD | PMID:21179406 |
| indole-3-methanol | decreases expression | ISO | RGD:1351014 | 6480464 | indole-3-carbinol results in decreased expression of CTSD protein | CTD | PMID:11110848 |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | alliin affects the reaction [Isoproterenol affects the activity of CTSD protein] | CTD | PMID:17623887 |
| isoprenaline | affects activity | ISO | RGD:621511 | 6480464 | Isoproterenol affects the activity of CTSD protein | CTD | PMID:17623887 more ... |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | epigallocatechin gallate inhibits the reaction [Isoproterenol affects the activity of CTSD protein] | CTD | PMID:18294627 |
| isoprenaline | affects activity | ISO | RGD:621511 | 6480464 | Isoproterenol affects the activity of CTSD protein | CTD | PMID:17623887 PMID:20391626 |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | caffeic acid inhibits the reaction [Isoproterenol affects the activity of CTSD protein] | CTD | PMID:20391626 |
| isoprenaline | increases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased activity of CTSD protein | CTD | PMID:11829124 more ... |
| isoprenaline | increases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased activity of CTSD protein | CTD | PMID:17188415 more ... |
| isoprenaline | decreases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in decreased activity of CTSD protein | CTD | PMID:14499179 more ... |
| isoprenaline | increases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased activity of CTSD protein | CTD | PMID:14499179 more ... |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:11829124 PMID:14499179 |
| isoprenaline | increases expression | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased expression of CTSD mRNA | CTD | PMID:17182065 PMID:894732 |
| isoprenaline | increases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased activity of CTSD protein | CTD | PMID:17188415 more ... |
| isoprenaline | decreases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in decreased activity of CTSD protein | CTD | PMID:14499179 more ... |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | S-allylcysteine inhibits the reaction [Isoproterenol results in increased expression of CTSD mRNA] | CTD | PMID:17182065 |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:14499179 PMID:11829124 |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | Plant Extracts inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:19641666 |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | naringin inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:17188415 |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein] | CTD | PMID:14499179 |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | Methylprednisolone inhibits the reaction [Isoproterenol results in increased expression of CTSD mRNA] | CTD | PMID:894732 |
| isoprenaline | increases expression | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased expression of CTSD protein | CTD | PMID:18424012 |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein] | CTD | PMID:19172585 |
| isoprenaline | increases expression | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased expression of CTSD mRNA | CTD | PMID:894732 PMID:17182065 |
| isoprenaline | increases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in increased activity of CTSD protein | CTD | PMID:21762681 more ... |
| isoprenaline | decreases activity | ISO | RGD:621511 | 6480464 | Isoproterenol results in decreased activity of CTSD protein | CTD | PMID:19172585 more ... |
| isoprenaline | affects activity | ISO | RGD:621511 | 6480464 | Isoproterenol affects the activity of CTSD protein | CTD | PMID:17623887 |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | [ferulic acid co-treated with Ascorbic Acid] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:17045618 |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | Ellagic Acid inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:21762681 |
| isoprenaline | multiple interactions | ISO | RGD:621511 | 6480464 | Curcumin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein]; more ... | CTD | PMID:8534267 |
| L-ascorbic acid | multiple interactions | ISO | RGD:621511 | 6480464 | [ferulic acid co-treated with Ascorbic Acid] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:17045618 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CTSD mRNA | CTD | PMID:20938992 |
| linalool | increases expression | ISO | RGD:1351014 | 6480464 | linalool results in increased expression of CTSD mRNA | CTD | PMID:19922762 |
| lipoic acid | multiple interactions | ISO | RGD:621511 | 6480464 | Thioctic Acid inhibits the reaction [Doxorubicin results in decreased activity of CTSD protein] | CTD | PMID:12841641 |
| lithium atom | increases expression | ISO | RGD:621511 | 6480464 | Lithium results in increased expression of CTSD protein | CTD | PMID:18296634 |
| lucanthone | increases expression | ISO | RGD:1351014 | 6480464 | Lucanthone results in increased expression of CTSD protein; more ... | CTD | PMID:21148553 |
| malathion | increases expression | EXP | | 6480464 | Malathion results in increased expression of CTSD protein | CTD | PMID:8812242 |
| mangiferin | multiple interactions | ISO | RGD:621511 | 6480464 | mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein] | CTD | PMID:19172585 |
| melatonin | multiple interactions | ISO | RGD:1351014 | 6480464 | Melatonin inhibits the reaction [Cadmium Chloride results in increased expression of CTSD] | CTD | PMID:22041583 |
| methamphetamine | affects localization | ISO | RGD:621511 | 6480464 | Methamphetamine affects the localization of CTSD protein | CTD | PMID:17105920 |
| methapyrilene | increases expression | ISO | RGD:621511 | 6480464 | Methapyrilene results in increased expression of CTSD mRNA | CTD | PMID:15890375 |
| N-nitrosodimethylamine | increases expression | ISO | RGD:621511 | 6480464 | Dimethylnitrosamine results in increased expression of CTSD mRNA | CTD | PMID:15890375 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | increases expression | ISO | RGD:1351014 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in increased expression of CTSD protein | CTD | PMID:10772776 |
| naringin | multiple interactions | ISO | RGD:621511 | 6480464 | naringin inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] | CTD | PMID:17188415 |
| nitric oxide | increases secretion | ISO | RGD:621511 | 6480464 | Nitric Oxide results in increased secretion of CTSD protein | CTD | PMID:15040013 |
| nitroglycerin | decreases expression | ISO | RGD:621511 | 6480464 | Nitroglycerin results in decreased expression of CTSD mRNA | CTD | PMID:12102619 |
| omeprazole | multiple interactions | ISO | RGD:621511 | 6480464 | Omeprazole inhibits the reaction [Cysteamine results in increased expression of CTSD protein] | CTD | PMID:20165931 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CTSD protein | CTD | PMID:8794998 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CTSD mRNA | CTD | PMID:17562736 |
| paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of CTSD mRNA | CTD | PMID:16797015 |
| phenacetin | increases expression | ISO | RGD:621511 | 6480464 | Phenacetin results in increased expression of CTSD mRNA | CTD | PMID:17698508 |
| phenobarbital | increases expression | ISO | RGD:621511 | 6480464 | Phenobarbital results in increased expression of CTSD mRNA | CTD | PMID:19162173 |
| phenylhydrazine | increases expression | ISO | RGD:621511 | 6480464 | phenylhydrazine results in increased expression of CTSD mRNA | CTD | PMID:17698508 |
| piperonyl butoxide | increases expression | ISO | RGD:621511 | 6480464 | Piperonyl Butoxide results in increased expression of CTSD mRNA | CTD | PMID:15890375 |
| piperonyl butoxide | increases expression | ISO | RGD:621511 | 6480464 | Piperonyl Butoxide results in increased expression of CTSD mRNA | CTD | PMID:15890375 PMID:22484513 |
| pirimiphos-methyl | decreases activity | ISO | RGD:621511 | 6480464 | pirimiphos methyl results in decreased activity of CTSD protein | CTD | PMID:9204212 |
| pirimiphos-methyl | increases activity | ISO | RGD:621511 | 6480464 | pirimiphos methyl results in increased activity of CTSD protein | CTD | PMID:9204212 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CTSD mRNA | CTD | PMID:18301758 PMID:20813756 |
| pirinixic acid | increases expression | ISO | RGD:621511 | 6480464 | pirinixic acid results in increased expression of CTSD mRNA | CTD | PMID:19162173 PMID:15890375 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CTSD mRNA | CTD | PMID:20813756 PMID:18301758 |
| pirinixic acid | increases expression | ISO | RGD:621511 | 6480464 | pirinixic acid results in increased expression of CTSD mRNA | CTD | PMID:15890375 PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:621511 | 6480464 | Pregnenolone Carbonitrile results in increased expression of CTSD mRNA | CTD | PMID:19162173 |
| pristane | increases expression | EXP | | 6480464 | pristane results in increased expression of CTSD protein | CTD | PMID:8812242 |
| pristane | multiple interactions | EXP | | 6480464 | [pristane co-treated with Cromolyn Sodium] results in increased expression of CTSD protein | CTD | PMID:8812242 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of CTSD mRNA | CTD | PMID:22334560 |
| quercetin | increases expression | ISO | RGD:1351014 | 6480464 | Quercetin results in increased expression of CTSD mRNA | CTD | PMID:15090535 |
| quercetin | increases expression | ISO | RGD:1351014 | 6480464 | Quercetin results in increased expression of CTSD mRNA | CTD | PMID:15090535 PMID:21632981 |
| resveratrol | increases expression | ISO | RGD:1351014 | 6480464 | resveratrol metabolite results in increased expression of CTSD mRNA | CTD | PMID:19496085 |
| resveratrol | increases expression | ISO | RGD:1351014 | 6480464 | resveratrol results in increased expression of CTSD mRNA | CTD | PMID:20878097 |
| resveratrol | increases expression | ISO | RGD:1351014 | 6480464 | resveratrol results in increased expression of CTSD protein | CTD | PMID:18089832 |
| resveratrol | increases expression | ISO | RGD:1351014 | 6480464 | resveratrol results in increased expression of CTSD | CTD | PMID:10402233 |
| resveratrol | decreases expression | ISO | RGD:1351014 | 6480464 | resveratrol results in decreased expression of CTSD mRNA | CTD | PMID:14750165 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CTSD mRNA | CTD | PMID:16081268 |
| resveratrol | increases secretion | ISO | RGD:1351014 | 6480464 | resveratrol results in increased secretion of CTSD protein | CTD | PMID:16393696 |
| resveratrol | affects expression | ISO | RGD:1351014 | 6480464 | resveratrol affects the expression of CTSD mRNA | CTD | PMID:16393696 |
| resveratrol | affects response to substance | ISO | RGD:1351014 | 6480464 | CTSD protein affects the susceptibility to resveratrol | CTD | PMID:17116725 |
| resveratrol | multiple interactions | ISO | RGD:1351014 | 6480464 | ESR1 protein affects the reaction [resveratrol affects the secretion of CTSD protein]; more ... | CTD | PMID:16393696 |
| resveratrol | multiple interactions | ISO | RGD:1351014 | 6480464 | CTSD protein affects the reaction [resveratrol affects the localization of CYCS protein]; more ... | CTD | PMID:17116725 |
| retinyl acetate | increases expression | EXP | | 6480464 | retinol acetate results in increased expression of CTSD mRNA | CTD | PMID:16772331 |
| stilben-4-ol | increases expression | ISO | RGD:1351014 | 6480464 | 4-hydroxystilbene results in increased expression of CTSD mRNA | CTD | PMID:19496085 |
| stilbene-4,4'-diol | increases expression | ISO | RGD:1351014 | 6480464 | 4,4'-dihydroxystilbene results in increased expression of CTSD mRNA | CTD | PMID:19496085 |
| tamibarotene | increases expression | ISO | RGD:1351014 | 6480464 | Am 80 results in increased expression of CTSD mRNA; more ... | CTD | PMID:15498508 |
| trans-resveratrol | increases expression | ISO | RGD:1351014 | 6480464 | resveratrol metabolite results in increased expression of CTSD mRNA | CTD | PMID:19496085 |
| trans-resveratrol | increases expression | ISO | RGD:1351014 | 6480464 | resveratrol results in increased expression of CTSD mRNA | CTD | PMID:20878097 |
| trans-resveratrol | increases expression | ISO | RGD:1351014 | 6480464 | resveratrol results in increased expression of CTSD protein | CTD | PMID:18089832 |
| trans-resveratrol | increases expression | ISO | RGD:1351014 | 6480464 | resveratrol results in increased expression of CTSD | CTD | PMID:10402233 |
| trans-resveratrol | decreases expression | ISO | RGD:1351014 | 6480464 | resveratrol results in decreased expression of CTSD mRNA | CTD | PMID:14750165 |
| trans-resveratrol | multiple interactions | ISO | RGD:1351014 | 6480464 | CTSD protein affects the reaction [resveratrol affects the localization of CYCS protein]; more ... | CTD | PMID:17116725 |
| trans-resveratrol | multiple interactions | ISO | RGD:1351014 | 6480464 | ESR1 protein affects the reaction [resveratrol affects the secretion of CTSD protein]; more ... | CTD | PMID:16393696 |
| trans-resveratrol | affects response to substance | ISO | RGD:1351014 | 6480464 | CTSD protein affects the susceptibility to resveratrol | CTD | PMID:17116725 |
| trans-resveratrol | affects expression | ISO | RGD:1351014 | 6480464 | resveratrol affects the expression of CTSD mRNA | CTD | PMID:16393696 |
| trans-resveratrol | increases secretion | ISO | RGD:1351014 | 6480464 | resveratrol results in increased secretion of CTSD protein | CTD | PMID:16393696 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CTSD mRNA | CTD | PMID:16081268 |
| vancomycin | decreases expression | EXP | | 6480464 | Vancomycin results in decreased expression of CTSD mRNA | CTD | PMID:18930951 |